EosDx
EosDx Inc. is pioneering a new modality in AI-powered cancer detection, focusing initially on breast cancer. The company has developed compact bio-crystallography technology combined with advanced machine learning to non-invasively and accurately detect pre-symptomatic cancer by analyzing the extracellular matrix at a molecular level. This approach enables fast, painless, and safe breast exams with over 90% sensitivity and specificity, providing objective digital results without human interpretation. EosDx operates on a cloud-based SaaS business model, aiming to save lives, reduce healthcare costs, and eliminate unnecessary medical procedures. Their technology also allows monitoring of cancer treatment efficacy, positioning them as a potential global leader in early cancer detection and treatment monitoring.
EosDx
EosDx Inc. is pioneering a new modality in AI-powered cancer detection, focusing initially on breast cancer. The company has developed compact bio-crystallography technology combined with advanced machine learning to non-invasively and accurately detect pre-symptomatic cancer by analyzing the extracellular matrix at a molecular level. This approach enables fast, painless, and safe breast exams with over 90% sensitivity and specificity, providing objective digital results without human interpretation. EosDx operates on a cloud-based SaaS business model, aiming to save lives, reduce healthcare costs, and eliminate unnecessary medical procedures. Their technology also allows monitoring of cancer treatment efficacy, positioning them as a potential global leader in early cancer detection and treatment monitoring.